Dr. Emily Park
InvestorPrincipal, DCVC Bio at DCVC Bio
About
Emily Park invests in early-stage therapeutics platform and computational biology companies at DCVC Bio, concentrating on drug development and pipeline strategy while advising portfolio companies on operations and fundraising. She previously worked in public markets as a biotech equities analyst at Point72 Asset Management and on Goldman Sachs' Global Investment Research team, and has consulted independently for hedge funds and TechBio companies. She holds a bachelor's degree in English literature from Columbia University and an MD from Rutgers New Jersey Medical School.
Invests in
AI & Machine LearningBiotech
Colleagues at DCVC Bio
Aimee Villamayor
Office Manager & Executive Assistant, DCVC Bio at DCVC Bio
Carly Smith
Office Assistant, DCVC Bio at DCVC Bio
Christopher Meldrum
Entrepreneur In Residence, DCVC Bio at DCVC Bio
Dr. Adil Anjem
Entrepreneur In Residence, DCVC Bio at DCVC Bio
Dr. Andy May
Operating Partner, DCVC Bio at DCVC Bio
Dr. John Hamer
Managing Partner, DCVC Bio at DCVC Bio
Dr. Justin Kern
Partner, DCVC Bio at DCVC Bio
Dr. Kiersten Stead
Managing Partner, DCVC Bio at DCVC Bio